Crossref
Quercetin overcomes gemcitabine resistance in pancreatic cancer by targeting TOP2A and WNT-β-catenin signaling
World Journal of Gastroenterology · 12.11.2026
DOI: 10.3748/wjg.123806 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 12.11.2026. Verfasst von Shi-Kang Deng und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Deng, S., Zhang, L., Meng, T., Wang, S., Chen, C., Qiao, O., & Jin, Y. (2026). Quercetin overcomes gemcitabine resistance in pancreatic cancer by targeting TOP2A and WNT-β-catenin signaling. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.123806
Vancouver
Deng S, Zhang L, Meng T, Wang S, Chen C, Qiao O, et al. Quercetin overcomes gemcitabine resistance in pancreatic cancer by targeting TOP2A and WNT-β-catenin signaling. World Journal of Gastroenterology. 2026. doi:10.3748/wjg.123806
BibTeX
@article{Deng2026,
author = {Deng, Shi-Kang and Zhang, Li and Meng, Tao-Fang and Wang, Sheng and Chen, Chen and Qiao, Ou and Jin, Yun},
title = {Quercetin overcomes gemcitabine resistance in pancreatic cancer by targeting TOP2A and WNT-β-catenin signaling},
journal = {World Journal of Gastroenterology},
year = {2026},
doi = {10.3748/wjg.123806}
}
EUVIMED